Sheng‐Nan Lu

机构：Chang Gung University, Kaohsiung Chang Gung Memorial Hospital · ORCID：0000-0002-5493-4752

发表论文 484 篇 · 总被引 17759 次 · h-index 65

代表论文

• Roadmap for HCC Surveillance and Management in the Asia Pacific (2025 · Cancers · 被引 9)
• Significant Decline in HCV ‐Related Mortality From Liver Cirrhosis and Chronic Liver Disease (2015–2022): A Sentinel Center Study (2025 · Liver International · 被引 3)
• National strategy for elimination of liver diseases in Taiwan (2025 · Journal of the Formosan Medical Association · 被引 2)
• Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis (2025 · Biomedical Journal · 被引 2)
• Survival outcome with liver resection versus percutaneous radiofrequency ablation in patients with 2–3 cm single hepatocellular carcinoma (2025 · Asian Journal of Surgery · 被引 2)
• Overall survival was inferior in octogenarians with early-stage hepatocellular carcinoma undergoing percutaneous radiofrequency ablation (2025 · The American Journal of the Medical Sciences · 被引 2)